FI871052A7 - Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. - Google Patents
Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.Info
- Publication number
- FI871052A7 FI871052A7 FI871052A FI871052A FI871052A7 FI 871052 A7 FI871052 A7 FI 871052A7 FI 871052 A FI871052 A FI 871052A FI 871052 A FI871052 A FI 871052A FI 871052 A7 FI871052 A7 FI 871052A7
- Authority
- FI
- Finland
- Prior art keywords
- och
- tiazoler
- oxazoler
- substituerade
- nya
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863608290 DE3608290A1 (de) | 1986-03-13 | 1986-03-13 | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE3608290 | 1986-03-13 | ||
| DE3621775 | 1986-06-28 | ||
| DE19863621775 DE3621775A1 (de) | 1986-03-13 | 1986-06-28 | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI871052A0 FI871052A0 (fi) | 1987-03-11 |
| FI871052A7 true FI871052A7 (fi) | 1987-09-14 |
| FI87777B FI87777B (fi) | 1992-11-13 |
| FI87777C FI87777C (fi) | 1993-02-25 |
Family
ID=25841907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI871052A FI87777C (fi) | 1986-03-13 | 1987-03-11 | Foerfarande foer framstaellning av terapeutiskt anvaendbara substituerade tiazoler och oxazoler |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5457205A (fi) |
| EP (1) | EP0239815B1 (fi) |
| JP (1) | JPH0784446B2 (fi) |
| KR (1) | KR870008876A (fi) |
| CA (1) | CA1296002C (fi) |
| DE (2) | DE3621775A1 (fi) |
| DK (1) | DK168991B1 (fi) |
| ES (1) | ES2040215T3 (fi) |
| FI (1) | FI87777C (fi) |
| GR (1) | GR3002839T3 (fi) |
| HK (1) | HK106494A (fi) |
| HU (1) | HU196974B (fi) |
| IE (1) | IE59800B1 (fi) |
| IL (1) | IL81874A (fi) |
| MX (1) | MX9202818A (fi) |
| NO (1) | NO172849C (fi) |
| PH (1) | PH23996A (fi) |
| PL (1) | PL154772B1 (fi) |
| PT (1) | PT84462B (fi) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3805382A1 (de) * | 1988-02-20 | 1989-08-31 | Boehringer Ingelheim Vetmed | Verwendung von thiazolen zur leistungssteigerung bei tieren |
| JP3003148B2 (ja) * | 1989-01-05 | 2000-01-24 | 藤沢薬品工業株式会社 | チアゾール化合物、その製造法およびそれを含有する医薬組成物 |
| HUT70422A (en) * | 1991-07-22 | 1995-10-30 | Pfizer | Chiral thiazole derivatives and process for preparing them |
| AU7084294A (en) * | 1993-07-14 | 1995-02-13 | Taisho Pharmaceutical Co., Ltd. | 5-acetylthiazoline oxime derivative |
| US6472387B1 (en) | 1996-10-07 | 2002-10-29 | Eli Lilly And Company | Methods of using compounds as neuro-protective agents |
| PT971709E (pt) | 1996-10-07 | 2003-09-30 | Lilly Co Eli | Novos compostos uteis como agentes neuro-protectores |
| DE69738809D1 (de) * | 1996-11-08 | 2008-08-14 | Nippon Chemiphar Co | Mittel zur verringerung der eigeweidefette |
| BR9812857A (pt) | 1997-10-06 | 2000-08-08 | Lilly Co Eli | Compostos úteis como agentes neuro-protetores |
| US5972099A (en) * | 1997-12-17 | 1999-10-26 | Bayer Corporation | Process for preparing organic pigment compositions |
| US6121300A (en) * | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| DE60108420T2 (de) * | 2000-11-28 | 2005-12-22 | Smithkline Beecham P.L.C., Brentford | Morpholinderivate als antagonisten an orexinrezeptoren |
| DK1633340T3 (da) * | 2003-04-15 | 2011-02-07 | Wellstat Therapeutics Corp | Forbindelser til behandling af stofskifteforstyrrelser |
| EP1618086B1 (en) | 2003-04-22 | 2009-12-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| GB0324654D0 (en) * | 2003-10-22 | 2003-11-26 | Glaxo Group Ltd | Medicinal compounds |
| TW200526588A (en) * | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
| JP6063948B2 (ja) * | 2011-10-27 | 2017-01-18 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | ベータ3アゴニストおよび中間体を製造するプロセス |
| US10791890B2 (en) | 2018-03-27 | 2020-10-06 | Omachron Intellectual Property Inc. | Surface cleaning apparatus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3225042A (en) * | 1962-07-31 | 1965-12-21 | Lilly Co Eli | Hydroxymorpholines |
| US3514465A (en) * | 1966-12-30 | 1970-05-26 | Degussa | Certain thiazolyl- and pyridinylaminoketones |
| LU69079A1 (fi) * | 1973-12-27 | 1975-08-20 | ||
| FI791727A7 (fi) * | 1978-06-05 | 1981-01-01 | Ciba Geigy Ag | Menetelmä N-alkyloitujen aminoalkoholien valmistamiseksi. |
| IE50355B1 (en) * | 1979-10-20 | 1986-04-02 | Wyeth John & Brother Ltd | Morpholine derivatives |
| GB8418657D0 (en) * | 1984-07-21 | 1984-08-22 | Beecham Group Plc | Compounds |
| US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
-
1986
- 1986-06-28 DE DE19863621775 patent/DE3621775A1/de not_active Ceased
-
1987
- 1987-03-03 EP EP87102995A patent/EP0239815B1/de not_active Expired - Lifetime
- 1987-03-03 ES ES198787102995T patent/ES2040215T3/es not_active Expired - Lifetime
- 1987-03-03 DE DE8787102995T patent/DE3771541D1/de not_active Expired - Lifetime
- 1987-03-10 PL PL1987264545A patent/PL154772B1/pl unknown
- 1987-03-11 CA CA000531681A patent/CA1296002C/en not_active Expired - Lifetime
- 1987-03-11 FI FI871052A patent/FI87777C/fi not_active IP Right Cessation
- 1987-03-12 HU HU871084A patent/HU196974B/hu not_active IP Right Cessation
- 1987-03-12 JP JP62055477A patent/JPH0784446B2/ja not_active Expired - Lifetime
- 1987-03-12 DK DK127487A patent/DK168991B1/da active
- 1987-03-12 IL IL81874A patent/IL81874A/xx not_active IP Right Cessation
- 1987-03-12 IE IE64487A patent/IE59800B1/en not_active IP Right Cessation
- 1987-03-12 PT PT84462A patent/PT84462B/pt not_active IP Right Cessation
- 1987-03-12 NO NO871028A patent/NO172849C/no unknown
- 1987-03-13 KR KR870002258A patent/KR870008876A/ko not_active Ceased
- 1987-03-13 PH PH35027A patent/PH23996A/en unknown
-
1991
- 1991-10-03 GR GR91401473T patent/GR3002839T3/el unknown
-
1992
- 1992-06-12 MX MX9202818A patent/MX9202818A/es unknown
-
1993
- 1993-03-12 US US08/030,744 patent/US5457205A/en not_active Expired - Fee Related
-
1994
- 1994-10-06 HK HK106494A patent/HK106494A/xx not_active IP Right Cessation
-
1995
- 1995-05-24 US US08/449,174 patent/US5604225A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI871052A0 (fi) | 1987-03-11 |
| PT84462B (pt) | 1989-10-04 |
| FI87777C (fi) | 1993-02-25 |
| IL81874A (en) | 1991-01-31 |
| EP0239815B1 (de) | 1991-07-24 |
| PL154772B1 (en) | 1991-09-30 |
| KR870008876A (ko) | 1987-10-21 |
| US5457205A (en) | 1995-10-10 |
| NO871028L (no) | 1987-09-14 |
| ES2040215T3 (es) | 1993-10-16 |
| DK127487D0 (da) | 1987-03-12 |
| CA1296002C (en) | 1992-02-18 |
| PT84462A (de) | 1987-04-01 |
| NO172849C (no) | 1993-09-15 |
| US5604225A (en) | 1997-02-18 |
| IL81874A0 (en) | 1987-10-20 |
| HK106494A (en) | 1994-10-14 |
| PL264545A1 (en) | 1988-07-21 |
| JPH0784446B2 (ja) | 1995-09-13 |
| GR3002839T3 (en) | 1993-01-25 |
| MX9202818A (es) | 1992-06-30 |
| FI87777B (fi) | 1992-11-13 |
| HU196974B (en) | 1989-02-28 |
| DE3621775A1 (de) | 1988-01-07 |
| JPS62226971A (ja) | 1987-10-05 |
| EP0239815A1 (de) | 1987-10-07 |
| DE3771541D1 (de) | 1991-08-29 |
| DK127487A (da) | 1987-09-14 |
| PH23996A (en) | 1990-02-09 |
| NO172849B (no) | 1993-06-07 |
| DK168991B1 (da) | 1994-07-25 |
| HUT44246A (en) | 1988-02-29 |
| IE59800B1 (en) | 1994-04-06 |
| IE870644L (en) | 1987-09-13 |
| NO871028D0 (no) | 1987-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI880546A7 (fi) | Nya kolfibriller, foerfarande foer framstaellning daerav och kompositioner innehaollande desamma. | |
| FI873142A7 (fi) | Nya benzolsulfonamido -indanylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI860971A0 (fi) | Nya sulfonylaminoetylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI886005A7 (fi) | Nya, sulfhydrylgrupper innehaollande tricykliska laktamer och deras farmakologiska anvaendningsfoerfaranden. | |
| FI892454L (fi) | Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma. | |
| FI875727L (fi) | Nya oligosackarider, immunogener och vacciner och foerfarande foer framstaellning av saodana oligosackarider, immunogener och vacciner. | |
| FI874323A7 (fi) | Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel. | |
| FI872841A0 (fi) | Nya kromoforfoereningar, solskyddskompositioner och foerfarande foer hindrande av solbraenna. | |
| FI870274A0 (fi) | Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster. | |
| FI871052A7 (fi) | Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI882385L (fi) | Fosforhaltiga hmg-coa -reduktasinhibitorer, foerfarande foer framstaellning daerav och nya mellanprodukter. | |
| FI883347A7 (fi) | Nya 5-aminometylen-2,4 -imidazolidindioner och 5-aminometylen-4-tionoimidazolidin-4-oner. | |
| FI875719A0 (fi) | Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI885811L (fi) | Nya ammoniumfoereningar, deras framstaellning och anvaendning. | |
| FI882477A7 (fi) | Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI875595A7 (fi) | Nya bicykliska difosfonatfoereningar, farmaceutiska kompositioner och foerfarande foer behandling av avvikande kalcium- och fosfatmetabolism. | |
| FI881816L (fi) | Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI875086A7 (fi) | Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI873917A7 (fi) | Nya naftalin- och indanderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI873934A7 (fi) | Nya naftylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI873243A0 (fi) | Nya 1,4-benzodiazepiner, deras framstaellning och anvaendning. | |
| FI873783A7 (fi) | Nya sulfonamido-etylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI885056L (fi) | Nya fluormetoxifenyldihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| FI872635A7 (fi) | Nya polypeptider, deras framstaellning och anvaendning. | |
| FI883745A7 (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: DR. KARL THOMAE GESELLSCHAFT MIT |